Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adverse Drug Reaction Frequency Investigation of TSUMURA Goreisan Extract Granules (TJ-17)
jRCT1031250586Recruiting
- Sponsor
- Tsumura & Co.
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of oreongsan in edema, nephrosis, alcohol hangover and 10 more, sponsored by Tsumura & Co. Primary endpoint: Safety. Started Feb 2026; status: recruiting.
02
Drugs
oreongsan
03
Conditions
edemanephrosisalcohol hangoveracute gastroenteritisdiarrhea
Beyond the preview
Go deeper on jRCT1031250586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031250586.